Hanmi Pharm. Co., Ltd.
Records under this name other than the patents Hanmi Pharm. Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 97 patents it holds.
Back to Hanmi Pharm. Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,513,426 | Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,888,511 | Method of preparing esomeprazole and salts thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,188,102 | Amide derivative for inhibiting the growth of cancer cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,112,954 | Bicyclic Heteroaryl Derivatives Having Inhibitory Activity for Protein Kinase Formerly held In force · High confidence | In force | High confidence | |
| US 11,396,534 | Insulin Analogs with Reduced Affinity to Insulin Receptor and Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,684,655 | Novel Methods of Treating Neutorpenia Using G-Csf Protein Complex Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,318,430 | Novel Methods of Treating Neutorpenia Using G-Csf Protein Complex Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,350,315 | Methods of Treating Neutorpenia Using G-Csf Protein Complex Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,227,510 | Crystal Form of Acid Addition Salt of Furopyrimidine Compound Formerly held In force · High confidence | In force | High confidence | |
| US 7,576,219 | Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same Formerly held In force Term ended Sep 29, 2026 · From the USPTO record | In force | Term ended Sep 29, 2026 | From the USPTO record |